Tetsuya Mori
3PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 29, 2025
Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in Japan.Tetsuya Mori, Akiko Kada, Tomoo Osumi
|Dec 19, 2023
Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.Tetsuya Mori, Tomoo Osumi, Akiko Kada
|Jan 22, 2020
Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma.Yuhki Koga, Masahiro Sekimizu, Akihiro Iguchi
Pageof 1
Frequent Collaborators
2 joint publications
Reiji Fukano
1 joint publications
Tomoo Osumi
1 joint publications
Akiko Kada
1 joint publications
Kentaro Ohki
1 joint publications
Yuhki Koga
1 joint publications
Naoto Fujita
1 joint publications
Tetsuo Mitsui
1 joint publications
Takeshi Mori
1 joint publications
Akiko M Saito
1 joint publications
Atsuko Nakazawa
